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Dear Editor, 
On behalf of all of the coauthors, I would like to thank 
Dr. Kamar for his interest in our study. In the letter, Dr. Ka-
mar summarized the most important ﬁndings on hepa-
titis E infection in organ transplant recipients (1), most 
of whom have relied on the valuable contributions by of 
Dr. Kamar’s group in France (2-4). In our study, we noted 
a high seroprevalence of anti-HEV IgG. Almost 30% of 
transplant recipients were seropositive for anti-HEV IgG 
(5). We also found unexplained increases in liver func-
tion tests in transplant recipients. However, there was no 
signiﬁcant diﬀerence in serum alanine transferase (ALT) 
levels between anti-HEV-seropositive and -seronegative 
groups (5).
As mentioned in the letter, serological methods have 
certain limitations. There are doubts regarding the di-
agnostic value of anti-HEV IgG serological evaluation in 
the diagnosis of HEV infection. In a study in Taiwan, an 
area in which hepatitis E is not endemic, the sensitivity of 
anti-HEV IgG compared with reverse-transcription PCR 
was 86.7% (6). Its speciﬁcity in diagnosing acute hepatitis 
was 92%. Lin et al. concluded that anti-HEV IgG is a good 
test for screening acute hepatitis E in nonendemic areas 
(6). Jiang et al. evaluated the quality of diagnostic ELISA 
kits in detecting HEV-speciﬁc IgG using HEV diagnostic 
reference sera from positive and negative cases, observ-
ing that the conformity of positive results exceeded 90% 
in all kits (7). In contrast, Zaki et al., in Egypt, an endemic 
area for hepatitis E, found the sensitivity of anti-HEV IgG 
to be very low (2.3%) (8). It appears that the diagnostic 
value of anti-HEV IgG serological tests in endemic areas 
is questionable. 
As emphasized by Dr. Kamar, the setting of transplant 
recipients in Iran requires further evaluation using more 
speciﬁc modalities, such as polymerase chain reaction 
(PCR). Studying the presence of HEV RNA, its relationship 
with elevated liver enzymes, and acute or chronic forms 
of infection in these patients is recommended. 
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